Clinical Trial: Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers

U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07102719) titled 'Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers' on July 30.

Brief Summary: The purpose of this study is to compare the pharmacokinetics and safety of HDP023 and coadministration of Teneligliptin and Empagliflozin in healthy adult volunteers

Study Start Date: Sept., 2025

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: HD-P023

Single dose administration of HD-P023

DRUG: Teneligliptin and Empagliflozin

Single does administration of Teneligliptin and Empagliflozin High

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Handok ...